Vident Advisory’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Sell
11,386
-19,393
-63% -$604K ﹤0.01% 1567
2025
Q4
$1.36M Sell
30,779
-3,444
-10% -$193K 0.01% 695
2025
Q3
$2.5M Sell
34,223
-1,348
-4% -$87.9K 0.02% 503
2025
Q2
$2.18M Buy
35,571
+4,639
+15% +$259K 0.02% 480
2025
Q1
$1.79M Buy
30,932
+21,608
+232% +$1.36M 0.03% 513
2024
Q4
$498K Sell
9,324
-3,285
-26% -$161K 0.01% 947
2024
Q3
$549K Sell
12,609
-19,330
-61% -$645K 0.01% 872
2024
Q2
$893K Buy
31,939
+1,566
+5% +$41.3K 0.02% 632
2024
Q1
$817K Buy
+30,373
New +$866K 0.02% 648

Other funds holding DOCS

Vident Advisory's DOCS Position: Q1 2026 in Review

Vident Advisory reduced its Doximity (DOCS) stake by 63% in Q1 2026, selling an estimated $604K and leaving 11,386 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

Vident Advisory first reported a position in DOCS in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.5M in Q3 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Vident Advisory held 11,386 shares of Doximity worth $265K as of Q1 2026.
  • Vident Advisory sold 19,393 Doximity shares in Q1 2026, an estimated $604K.
  • Doximity made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1567 holding.
  • Vident Advisory first reported a position in Doximity in Q1 2024 and has held it in 9 quarters since.
  • Vident Advisory's Doximity position peaked at $2.5M in Q3 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.